TEXXON HOLDING LTD (NPT) Fundamental Analysis & Valuation

NASDAQ:NPTKYG8772G1064

Current stock price

1.77 USD
+0.01 (+0.57%)
Last:

This NPT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NPT Profitability Analysis

1.1 Basic Checks

  • In the past year NPT has reported negative net income.
  • NPT had a positive operating cash flow in the past year.
NPT Yearly Net Income VS EBIT VS OCF VS FCFNPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 20M -20M 40M -40M -60M

1.2 Ratios

  • NPT has a worse Return On Assets (-2.05%) than 69.57% of its industry peers.
Industry RankSector Rank
ROA -2.05%
ROE N/A
ROIC N/A
ROA(3y)1.03%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NPT Yearly ROA, ROE, ROICNPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 20 -20

1.3 Margins

  • NPT has a Gross Margin of 0.66%. This is amonst the worse of the industry: NPT underperforms 95.65% of its industry peers.
  • In the last couple of years the Gross Margin of NPT has grown nicely.
  • NPT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 0.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.63%
GM growth 5YN/A
NPT Yearly Profit, Operating, Gross MarginsNPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 0.2 -0.2 0.4 0.6

2

2. NPT Health Analysis

2.1 Basic Checks

  • NPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NPT has about the same amount of shares outstanding.
  • The debt/assets ratio for NPT is higher compared to a year ago.
NPT Yearly Shares OutstandingNPT Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 5M 10M 15M 20M
NPT Yearly Total Debt VS Total AssetsNPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 9.07 indicates that NPT is not in any danger for bankruptcy at the moment.
  • NPT has a better Altman-Z score (9.07) than 91.30% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 9.07
ROIC/WACCN/A
WACC7.63%
NPT Yearly LT Debt VS Equity VS FCFNPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 20M -20M 40M -40M -60M

2.3 Liquidity

  • A Current Ratio of 0.29 indicates that NPT may have some problems paying its short term obligations.
  • The Current ratio of NPT (0.29) is worse than 95.65% of its industry peers.
  • NPT has a Quick Ratio of 0.29. This is a bad value and indicates that NPT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NPT's Quick ratio of 0.27 is on the low side compared to the rest of the industry. NPT is outperformed by 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.27
NPT Yearly Current Assets VS Current LiabilitesNPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 20M 40M 60M

3

3. NPT Growth Analysis

3.1 Past

  • NPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -230.82%.
  • Looking at the last year, NPT shows a very strong growth in Revenue. The Revenue has grown by 31.00%.
  • NPT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.66% yearly.
EPS 1Y (TTM)-230.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-197.67%
Revenue 1Y (TTM)31%
Revenue growth 3Y17.66%
Revenue growth 5YN/A
Sales Q2Q%18.51%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NPT Yearly Revenue VS EstimatesNPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 200M 400M 600M

0

4. NPT Valuation Analysis

4.1 Price/Earnings Ratio

  • NPT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NPT Price Earnings VS Forward Price EarningsNPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NPT is valued more expensive than 80.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 431.77
NPT Per share dataNPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. NPT Dividend Analysis

5.1 Amount

  • No dividends for NPT!.
Industry RankSector Rank
Dividend Yield 0%

NPT Fundamentals: All Metrics, Ratios and Statistics

TEXXON HOLDING LTD

NASDAQ:NPT (4/30/2026, 9:35:40 AM)

1.77

+0.01 (+0.57%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap39.26M
Revenue(TTM)1.31B
Net Income(TTM)-2.85M
AnalystsN/A
Price TargetN/A
Short Float %3.03%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF 16.89
P/B N/A
P/tB N/A
EV/EBITDA 431.77
EPS(TTM)-0.13
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.93
FCFYN/A
OCF(TTM)0.1
OCFY5.92%
SpS58.91
BVpS-0.17
TBVpS-0.45
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -2.05%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 0.66%
FCFM N/A
ROA(3y)1.03%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.63%
GM growth 5YN/A
F-Score2
Asset Turnover9.4
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 349.06
Cap/Depr 15655.5%
Cap/Sales 3.45%
Interest Coverage N/A
Cash Conversion 1461.35%
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.27
Altman-Z 9.07
F-Score2
WACC7.63%
ROIC/WACCN/A
Cap/Depr(3y)12448.9%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.31%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-230.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-197.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)31%
Revenue growth 3Y17.66%
Revenue growth 5YN/A
Sales Q2Q%18.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-110.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107.55%
OCF growth 3Y-63.6%
OCF growth 5YN/A

TEXXON HOLDING LTD / NPT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TEXXON HOLDING LTD?

ChartMill assigns a fundamental rating of 2 / 10 to NPT.


What is the valuation status for NPT stock?

ChartMill assigns a valuation rating of 0 / 10 to TEXXON HOLDING LTD (NPT). This can be considered as Overvalued.


How profitable is TEXXON HOLDING LTD (NPT) stock?

TEXXON HOLDING LTD (NPT) has a profitability rating of 1 / 10.


How financially healthy is TEXXON HOLDING LTD?

The financial health rating of TEXXON HOLDING LTD (NPT) is 2 / 10.